Recently, a team led by Prof. LI Dacheng from Hefei Institutes of Physical Science (HFIPS), Chinese Academy of Sciences (CAS), developed a high-spectral device capable of meeting high-precision continuous measurements–the Ground-based Infrared Hyperspectral Spectrometer. This device is designed to continuously and accurately assess the radiation characteristics of both the atmosphere and the Earth's surface, providing crucial data to better understand changes in our environment.
With the help of the Nuclear Magnetic Resonance (NMR) spectrometer, a research group led by Prof. WANG Hui from High Magnetic Field Laboratory, Hefei Institutes of Physical Science of Chinese Academy of Sciences, successfully prepared a carbon-covered hollow cuprous oxide high-efficiency catalyst by using solvent autocarbonylation reduction strategy, which offered a new solution for the electrocatalytic CO2 Reduction Reaction (CO2RR) during the preparation of multicarbon (C2+) products.
A research team led by Prof. MENG Guowen and Prof. HAN Fangming from the Hefei Institutes of Physical Science (HFIPS), Chinese Academy of Sciences (CAS), along with Prof. WEI Bingqing from the University of Delaware, miniaturized line-filtering capacitors featuring "Matryoshka doll" structure electrodes, which provided a powerful and space-saving solution for line-filtering applications. The research was published in Joule recently.
According to a research published on Nano Energy recently,a group led by Prof. CHEN Chong from Hefei Institutes of Physical Science (HFIPS) of Chinese Academy of Sciences (CAS)successfully increased the photoelectric conversion efficiency (PCE) of perovskite solar cells (PSCs) to 24.5%.
As the world celebrates 2024 International Women's Day, our spotlight shines on a pioneering research team at Hefei Institutes of Physical Science (HFIPS) of Chinese Academy of Sciences (CAS) focused on precision anti-tumor drugs. With women comprising over 60% of the team, they have made significant advancements in cell engineering technology and cancer drug discovery. To meet the unmet clinical needs, the team has established innovative strategies, developed a serious of novel anti-tumor drug candidates, and explored technologies for precision medicine.